{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T23:52:48Z","timestamp":1790898768715,"version":"4.1.0"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,10,18]],"date-time":"2024-10-18T00:00:00Z","timestamp":1729209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,10,18]],"date-time":"2024-10-18T00:00:00Z","timestamp":1729209600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Diabetol Metab Syndr"],"DOI":"10.1186\/s13098-024-01483-w","type":"journal-article","created":{"date-parts":[[2024,10,18]],"date-time":"2024-10-18T04:02:36Z","timestamp":1729224156000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["The role of incretins in gestational diabetes: a case-control study on the impact of obesity"],"prefix":"10.1186","volume":"16","author":[{"given":"Engin","family":"Yurtcu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Betul","family":"Keyif","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gamze","family":"Yilmaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Selcuk","family":"Erkilinc","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hatice","family":"Akkaya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. Seval","family":"Ozgu-Erdinc","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,10,18]]},"reference":[{"issue":"1","key":"1483_CR1","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1097\/MCO.0000000000000238","volume":"19","author":"S Soenen","year":"2016","unstructured":"Soenen S, Rayner CK, Jones KL, Horowitz M. The ageing gastrointestinal tract. Curr Opin Clin Nutr Metab Care. 2016;19(1):12\u20138.","journal-title":"Curr Opin Clin Nutr Metab Care"},{"issue":"5","key":"1483_CR2","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1016\/j.cmet.2019.07.013","volume":"30","author":"AE Adriaenssens","year":"2019","unstructured":"Adriaenssens AE, Biggs EK, Darwish T, Tadross J, Sukthankar T, Girish M, et al. Glucose-dependent insulinotropic polypeptide receptor-expressing cells in the Hypothalamus regulate Food Intake. Cell Metab. 2019;30(5):987\u2013e966.","journal-title":"Cell Metab"},{"issue":"11","key":"1483_CR3","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.1111\/j.1365-2982.2010.01554.x","volume":"22","author":"T Edholm","year":"2010","unstructured":"Edholm T, Degerblad M, Gryb\u00e4ck P, Hilsted L, Holst JJ, Jacobsson H, et al. Differential incretin effects of GIP and GLP-1 on gastric emptying, appetite, and insulin-glucose homeostasis. Neurogastroenterol Motil. 2010;22(11):1191\u2013200. e315.","journal-title":"Neurogastroenterol Motil"},{"issue":"6","key":"1483_CR4","doi-asserted-by":"publisher","first-page":"1237","DOI":"10.1016\/j.soard.2015.03.021","volume":"11","author":"BJ Nerg\u00e5rd","year":"2015","unstructured":"Nerg\u00e5rd BJ, Lindqvist A, Gislason HG, Groop L, Ekelund M, Wierup N, et al. Mucosal glucagon-like peptide-1 and glucose-dependent insulinotropic polypeptide cell numbers in the super-obese human foregut after gastric bypass. Surg Obes Relat Dis. 2015;11(6):1237\u201346.","journal-title":"Surg Obes Relat Dis"},{"issue":"6","key":"1483_CR5","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1016\/S2213-8587(15)00482-9","volume":"4","author":"MA Nauck","year":"2016","unstructured":"Nauck MA, Meier JJ. The incretin effect in healthy individuals and those with type 2 diabetes: physiology, pathophysiology, and response to therapeutic interventions. Lancet Diabetes Endocrinol. 2016;4(6):525\u201336.","journal-title":"Lancet Diabetes Endocrinol"},{"key":"1483_CR6","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.peptides.2013.01.014","volume":"44","author":"CS Marathe","year":"2013","unstructured":"Marathe CS, Rayner CK, Jones KL, Horowitz M. Glucagon-like peptides 1 and 2 in health and disease: a review. Peptides. 2013;44:75\u201386.","journal-title":"Peptides"},{"issue":"Suppl 1","key":"1483_CR7","doi-asserted-by":"publisher","first-page":"S26","DOI":"10.1016\/S0168-8227(09)70006-3","volume":"86","author":"RE van Genugten","year":"2009","unstructured":"van Genugten RE, van Raalte DH, Diamant M. Does glucagon-like peptide-1 receptor agonist therapy add value in the treatment of type 2 diabetes? Focus on exenatide. Diabetes Res Clin Pract. 2009;86(Suppl 1):S26\u201334.","journal-title":"Diabetes Res Clin Pract"},{"issue":"10","key":"1483_CR8","doi-asserted-by":"publisher","first-page":"1495","DOI":"10.1517\/14728220903241633","volume":"18","author":"M Rizzo","year":"2009","unstructured":"Rizzo M, Rizvi AA, Spinas GA, Rini GB, Berneis K. Glucose lowering and anti-atherogenic effects of incretin-based therapies: GLP-1 analogues and DPP-4-inhibitors. Expert Opin Investig Drugs. 2009;18(10):1495\u2013503.","journal-title":"Expert Opin Investig Drugs"},{"issue":"2","key":"1483_CR9","doi-asserted-by":"publisher","first-page":"e23258","DOI":"10.1002\/jbt.23258","volume":"37","author":"L You","year":"2023","unstructured":"You L, Deng Y, Li D, Lin Y, Wang Y. GLP-1 rescued gestational diabetes mellitus-induced suppression of fetal thalamus development. J Biochem Mol Toxicol. 2023;37(2):e23258.","journal-title":"J Biochem Mol Toxicol"},{"issue":"7","key":"1483_CR10","doi-asserted-by":"publisher","first-page":"597","DOI":"10.2174\/1389201017666160127110125","volume":"17","author":"D Nikolic","year":"2016","unstructured":"Nikolic D, Al-Rasadi K, Al Busaidi N, Al-Waili K, Banerjee Y, Al-Hashmi K, et al. Incretins, pregnancy, and gestational diabetes. Curr Pharm Biotechnol. 2016;17(7):597\u2013602.","journal-title":"Curr Pharm Biotechnol"},{"issue":"12","key":"1483_CR11","doi-asserted-by":"publisher","first-page":"1635","DOI":"10.1007\/s00592-023-02142-8","volume":"60","author":"DL Jones","year":"2023","unstructured":"Jones DL, Petry CJ, Burling K, Barker P, Turner EH, Kusinski LC, et al. Pregnancy glucagon-like peptide 1 predicts insulin but not glucose concentrations. Acta Diabetol. 2023;60(12):1635\u201342.","journal-title":"Acta Diabetol"},{"issue":"1","key":"1483_CR12","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1080\/09513590601137004","volume":"23","author":"K Cypryk","year":"2007","unstructured":"Cypryk K, Vilsb\u00f8ll T, Nadel I, Smyczy\u0144ska J, Holst JJ, Lewi\u0144ski A. Normal secretion of the incretin hormones glucose-dependent insulinotropic polypeptide and glucagon-like peptide-1 during gestational diabetes mellitus. Gynecol Endocrinol. 2007;23(1):58\u201362.","journal-title":"Gynecol Endocrinol"},{"issue":"9","key":"1483_CR13","first-page":"e287","volume":"34","author":"C Lencioni","year":"2011","unstructured":"Lencioni C, Resi V, Romero F, Lupi R, Volpe L, Bertolotto A, et al. Glucagon-like peptide-1 secretion in women with gestational diabetes mellitus during and after pregnancy. J Endocrinol Invest. 2011;34(9):e287\u201390.","journal-title":"J Endocrinol Invest"},{"key":"1483_CR14","doi-asserted-by":"publisher","first-page":"838410","DOI":"10.3389\/fendo.2022.838410","volume":"13","author":"Q Tan","year":"2022","unstructured":"Tan Q, Akindehin SE, Orsso CE, Waldner RC, DiMarchi RD, M\u00fcller TD, et al. Recent advances in Incretin-based pharmacotherapies for the Treatment of Obesity and diabetes. Front Endocrinol (Lausanne). 2022;13:838410.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"6","key":"1483_CR15","doi-asserted-by":"publisher","first-page":"e2425","DOI":"10.1210\/clinem\/dgac095","volume":"107","author":"L Fritsche","year":"2022","unstructured":"Fritsche L, Heni M, Eckstein SS, Hummel J, Sch\u00fcrmann A, H\u00e4ring HU, et al. Incretin Hypersecretion in Gestational Diabetes Mellitus. J Clin Endocrinol Metab. 2022;107(6):e2425\u201330.","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"1483_CR16","first-page":"16","volume":"28","author":"E Yurtcu","year":"2022","unstructured":"Yurtcu E, Mutlu S, Ozkaya E. The effects of Pre-pregnancy Body Mass Index and Weight Gain during pregnancy on perinatal outcomes: a retrospective cohort study. Gynecol Obstet Reproductive Med. 2022;28(1):16\u201322.","journal-title":"Gynecol Obstet Reproductive Med"},{"issue":"3","key":"1483_CR17","doi-asserted-by":"publisher","first-page":"676","DOI":"10.2337\/dc09-1848","volume":"33","author":"BE Metzger","year":"2010","unstructured":"Metzger BE, Gabbe SG, Persson B, Buchanan TA, Catalano PA, Damm P, et al. International association of diabetes and pregnancy study groups recommendations on the diagnosis and classification of hyperglycemia in pregnancy. Diabetes Care. 2010;33(3):676\u201382.","journal-title":"Diabetes Care"},{"issue":"Supplement1","key":"1483_CR18","first-page":"S183","volume":"43","author":"AD Association","year":"2019","unstructured":"Association AD. 14. Management of diabetes in pregnancy: standards of Medical Care in Diabetes\u20142020. Diabetes Care. 2019;43(Supplement1):S183\u201392.","journal-title":"Diabetes Care"},{"key":"1483_CR19","doi-asserted-by":"crossref","unstructured":"Forzano I, Varzideh F, Avvisato R, Jankauskas SS, Mone P, Santulli G. Tirzepatide: a systematic update. Int J Mol Sci. 2022;23(23).","DOI":"10.3390\/ijms232314631"},{"issue":"8","key":"1483_CR20","doi-asserted-by":"publisher","first-page":"e2710","DOI":"10.1210\/clinem\/dgaa327","volume":"105","author":"JJ Holst","year":"2020","unstructured":"Holst JJ, Rosenkilde MM. GIP as a therapeutic target in diabetes and obesity: insight from Incretin co-agonists. J Clin Endocrinol Metab. 2020;105(8):e2710\u20136.","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"1483_CR21","doi-asserted-by":"publisher","first-page":"R57","DOI":"10.1530\/JOE-16-0035","volume":"229","author":"A Amato","year":"2016","unstructured":"Amato A, Baldassano S, Mul\u00e8 F. GLP2: an underestimated signal for improving glycaemic control and insulin sensitivity. J Endocrinol. 2016;229(2):R57\u201366.","journal-title":"J Endocrinol"},{"key":"1483_CR22","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1590\/s0004-2803.201800000-14","volume":"55","author":"E Cazzo","year":"2018","unstructured":"Cazzo E, Pareja JC, Chaim EA, Coy CSR, Magro DO. Comparison of the levels of C-reactive protein, GLP-1 and GLP-2 among individuals with diabetes, morbid obesity and healthy controls: an exploratory study. Arq Gastroenterol. 2018;55:72\u20137.","journal-title":"Arq Gastroenterol"},{"issue":"10","key":"1483_CR23","doi-asserted-by":"publisher","first-page":"1765","DOI":"10.1007\/s00125-023-05906-7","volume":"66","author":"DJ Drucker","year":"2023","unstructured":"Drucker DJ, Holst JJ. The expanding incretin universe: from basic biology to clinical translation. Diabetologia. 2023;66(10):1765\u201379.","journal-title":"Diabetologia"},{"issue":"2","key":"1483_CR24","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1111\/jdi.12398","volume":"7","author":"MC Amato","year":"2016","unstructured":"Amato MC, Pizzolanti G, Torregrossa V, Pant\u00f2 F, Giordano C. Phenotyping of type 2 diabetes mellitus at onset on the basis of fasting incretin tone: results of a two-step cluster analysis. J Diabetes Investig. 2016;7(2):219\u201325.","journal-title":"J Diabetes Investig"},{"issue":"5","key":"1483_CR25","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1007\/s00125-013-2841-0","volume":"56","author":"S Calanna","year":"2013","unstructured":"Calanna S, Christensen M, Holst JJ, Laferr\u00e8re B, Gluud LL, Vilsb\u00f8ll T, et al. Secretion of glucagon-like peptide-1 in patients with type 2 diabetes mellitus: systematic review and meta-analyses of clinical studies. Diabetologia. 2013;56(5):965\u201372.","journal-title":"Diabetologia"},{"issue":"Suppl 2","key":"1483_CR26","doi-asserted-by":"publisher","first-page":"S251","DOI":"10.2337\/dc11-s227","volume":"34","author":"JJ Holst","year":"2011","unstructured":"Holst JJ, Knop FK, Vilsb\u00f8ll T, Krarup T, Madsbad S. Loss of incretin effect is a specific, important, and early characteristic of type 2 diabetes. Diabetes Care. 2011;34(Suppl 2):S251\u20137.","journal-title":"Diabetes Care"},{"key":"1483_CR27","doi-asserted-by":"publisher","first-page":"9072492","DOI":"10.1155\/2020\/9072492","volume":"2020","author":"M Mosavat","year":"2020","unstructured":"Mosavat M, Omar SZ, Jamalpour S, Tan PC. Serum glucose-dependent Insulinotropic polypeptide (GIP) and Glucagon-Like Peptide-1 (GLP-1) in association with the risk of gestational diabetes: a prospective case-control study. J Diabetes Res. 2020;2020:9072492.","journal-title":"J Diabetes Res"},{"issue":"1","key":"1483_CR28","doi-asserted-by":"publisher","first-page":"71","DOI":"10.4103\/ijem.ijem_7_23","volume":"28","author":"N Narayanan","year":"2024","unstructured":"Narayanan N, Sahoo J, Kamalanathan S, Sagili H, Zachariah B, Naik D, et al. Insulin sensitivity, islet cell function, and Incretin Axis in pregnant women with and without gestational diabetes Mellitus. Indian J Endocrinol Metab. 2024;28(1):71\u20139.","journal-title":"Indian J Endocrinol Metab"},{"key":"1483_CR29","doi-asserted-by":"publisher","first-page":"102469","DOI":"10.1016\/j.bpobgyn.2024.102469","volume":"93","author":"M Bashir","year":"2024","unstructured":"Bashir M, Fagier Y, Ahmed B. An overview of diabetes mellitus in pregnant women with obesity. Best Pract Res Clin Obstet Gynaecol. 2024;93:102469.","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"issue":"1","key":"1483_CR30","doi-asserted-by":"publisher","first-page":"S106","DOI":"10.1016\/j.ajog.2010.10.264","volume":"204","author":"C Avila","year":"2011","unstructured":"Avila C, Garduno E, Chen J, Lane A, Ahn HJ, Santorelli J, et al. 246: fasting plasma active glucagon-like peptide-1 (GLP-1) in pregnancies with and without gestational diabetes (GDM). Am J Obstet Gynecol. 2011;204(1):S106.","journal-title":"Am J Obstet Gynecol"},{"issue":"6","key":"1483_CR31","doi-asserted-by":"publisher","first-page":"e13435","DOI":"10.1111\/obr.13435","volume":"23","author":"J Iqbal","year":"2022","unstructured":"Iqbal J, Wu HX, Hu N, Zhou YH, Li L, Xiao F, et al. Effect of glucagon-like peptide-1 receptor agonists on body weight in adults with obesity without diabetes mellitus-a systematic review and meta-analysis of randomized control trials. Obes Rev. 2022;23(6):e13435.","journal-title":"Obes Rev"},{"issue":"1","key":"1483_CR32","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1111\/j.2047-6310.2012.00140.x","volume":"9","author":"PC Chandler-Laney","year":"2014","unstructured":"Chandler-Laney PC, Bush NC, Rouse DJ, Mancuso MS, Gower BA. Gut hormone activity of children born to women with and without gestational diabetes. Pediatr Obes. 2014;9(1):53\u201362.","journal-title":"Pediatr Obes"},{"issue":"8","key":"1483_CR33","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1007\/s00125-002-0878-6","volume":"45","author":"T Vilsb\u00f8ll","year":"2002","unstructured":"Vilsb\u00f8ll T, Krarup T, Madsbad S, Holst JJ. Defective amplification of the late phase insulin response to glucose by GIP in obese type II diabetic patients. Diabetologia. 2002;45(8):1111\u20139.","journal-title":"Diabetologia"},{"issue":"1","key":"1483_CR34","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/s13098-023-00981-7","volume":"15","author":"O Krystynik","year":"2023","unstructured":"Krystynik O, Karasek D, Kahle M, Kubickova V, Macakova D, Cibickova L, et al. Non-altered incretin secretion in women with impaired fasting plasma glucose in the early stage of pregnancy: a case control study. Diabetol Metab Syndr. 2023;15(1):12.","journal-title":"Diabetol Metab Syndr"},{"issue":"1","key":"1483_CR35","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1053\/j.gastro.2005.10.004","volume":"130","author":"JJ Meier","year":"2006","unstructured":"Meier JJ, Nauck MA, Pott A, Heinze K, Goetze O, Bulut K, et al. Glucagon-like peptide 2 stimulates glucagon secretion, enhances lipid absorption, and inhibits gastric acid secretion in humans. Gastroenterology. 2006;130(1):44\u201354.","journal-title":"Gastroenterology"},{"key":"1483_CR36","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1146\/annurev-physiol-021113-170317","volume":"76","author":"DJ Drucker","year":"2014","unstructured":"Drucker DJ, Yusta B. Physiology and pharmacology of the enteroendocrine hormone glucagon-like peptide-2. Annu Rev Physiol. 2014;76:561\u201383.","journal-title":"Annu Rev Physiol"},{"issue":"8","key":"1483_CR37","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1590\/S0004-27302013000800008","volume":"57","author":"B Geloneze","year":"2013","unstructured":"Geloneze B, Lima MM, Pareja JC, Barreto MR, Magro DO. Association of insulin resistance and GLP-2 secretion in obesity: a pilot study. Arq Bras Endocrinol Metabol. 2013;57(8):632\u20135.","journal-title":"Arq Bras Endocrinol Metabol"},{"issue":"1\u20133","key":"1483_CR38","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.regpep.2010.05.004","volume":"163","author":"M Christensen","year":"2010","unstructured":"Christensen M, Knop FK, Vilsb\u00f8ll T, Aaboe K, Holst JJ, Madsbad S, et al. Glucagon-like peptide-2, but not glucose-dependent insulinotropic polypeptide, stimulates glucagon release in patients with type 1 diabetes. Regul Pept. 2010;163(1\u20133):96\u2013101.","journal-title":"Regul Pept"},{"issue":"6","key":"1483_CR39","doi-asserted-by":"publisher","first-page":"E1038","DOI":"10.1152\/ajpendo.00665.2010","volume":"300","author":"A Lund","year":"2011","unstructured":"Lund A, Vilsb\u00f8ll T, Bagger JI, Holst JJ, Knop FK. The separate and combined impact of the intestinal hormones, GIP, GLP-1, and GLP-2, on glucagon secretion in type 2 diabetes. Am J Physiol Endocrinol Metab. 2011;300(6):E1038\u201346.","journal-title":"Am J Physiol Endocrinol Metab"},{"issue":"3","key":"1483_CR40","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1530\/JOE-13-0184","volume":"218","author":"CY Shan","year":"2013","unstructured":"Shan CY, Yang JH, Kong Y, Wang XY, Zheng MY, Xu YG, et al. Alteration of the intestinal barrier and GLP2 secretion in Berberine-treated type 2 diabetic rats. J Endocrinol. 2013;218(3):255\u201362.","journal-title":"J Endocrinol"},{"issue":"4","key":"1483_CR41","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1055\/s-0041-1728828","volume":"40","author":"MK Kahr","year":"2023","unstructured":"Kahr MK, Antony KM, Galindo M, Whitham M, Hu M, Aagaard KM, et al. SERUM GLP-2 is increased in association with excess Gestational Weight Gain. Am J Perinatol. 2023;40(4):400\u20136.","journal-title":"Am J Perinatol"},{"key":"1483_CR42","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.ejogrb.2020.04.064","volume":"250","author":"EG O\u2019Malley","year":"2020","unstructured":"O\u2019Malley EG, Reynolds CME, Killalea A, O\u2019Kelly R, Sheehan SR, Turner MJ. The use of biomarkers at the end of the second trimester to predict gestational diabetes Mellitus. Eur J Obstet Gynecol Reprod Biol. 2020;250:101\u20136.","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"8","key":"1483_CR43","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1111\/dom.12082","volume":"15","author":"L Bonde","year":"2013","unstructured":"Bonde L, Vilsb\u00f8ll T, Nielsen T, Bagger JI, Svare JA, Holst JJ, et al. Reduced postprandial GLP-1 responses in women with gestational diabetes mellitus. Diabetes Obes Metab. 2013;15(8):713\u201320.","journal-title":"Diabetes Obes Metab"}],"container-title":["Diabetology & Metabolic Syndrome"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13098-024-01483-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13098-024-01483-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13098-024-01483-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,18]],"date-time":"2024-10-18T15:11:22Z","timestamp":1729264282000},"score":1,"resource":{"primary":{"URL":"https:\/\/dmsjournal.biomedcentral.com\/articles\/10.1186\/s13098-024-01483-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,18]]},"references-count":43,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["1483"],"URL":"https:\/\/doi.org\/10.1186\/s13098-024-01483-w","relation":{},"ISSN":["1758-5996"],"issn-type":[{"value":"1758-5996","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10,18]]},"assertion":[{"value":"7 June 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 October 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 October 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The protocol of this study was approved by the Duzce University Faculty of Medicine Ethics Committee (Ethics Committee Reference Number:2021\/161) and written informed consent was obtained from all the participants.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"248"}}